Effects of vaccine on rotavirus disease in the pediatric population
- 1 February 2012
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Pediatrics
- Vol. 24 (1), 76-84
- https://doi.org/10.1097/mop.0b013e32834ee594
Abstract
Rotavirus infection is the most common cause of severe diarrhea disease in infants and young children worldwide and continues to have a major global impact on childhood morbidity and mortality. Two effective rotavirus vaccines are available and recommended for routine immunization of all infants. These vaccines have been introduced in both developed and developing countries. As rotavirus vaccines are implemented, studies have been undertaken that assess the effects of vaccination on rotavirus disease in children. This review summarizes the results of these studies. Studies that assess health impact, indirect benefits, and strain changes after the introduction of rotavirus vaccine have been reported. In industrialized countries, rotavirus vaccination has led to dramatic drops in severe rotavirus-related hospitalizations and has reduced emergency room visits. Data from clinical trials in developing counties in Asia and Africa have demonstrated that rotavirus vaccines significantly reduce severe diarrhea episodes due to rotavirus. Herd (community) immunity has also been noted after routine rotavirus immunization in several countries. There have been no significant strain shifts or escape mutants noted since the introduction of rotavirus vaccines. Two well tolerated and effective rotavirus vaccines have reduced the health burden of rotavirus gastroenteritis in both developed and developing countries.Keywords
This publication has 69 references indexed in Scilit:
- Assessing the Effectiveness and Public Health Impact of Rotavirus Vaccines after Introduction in Immunization ProgramsThe Journal of Infectious Diseases, 2009
- Rotavirus OverviewThe Pediatric Infectious Disease Journal, 2009
- Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III studyThe Lancet, 2008
- Hospitalizations and Deaths from Diarrhea and Rotavirus among Children <5 Years of Age in the United States, 1993–2003The Journal of Infectious Diseases, 2007
- Diarrhea- and Rotavirus-Associated Hospitalizations Among Children Less Than 5 Years of Age: United States, 1997 and 2000Published by American Academy of Pediatrics (AAP) ,2006
- TEMPORAL AND GEOGRAPHIC TRENDS OF ROTAVIRUS ACTIVITY IN THE UNITED STATES, 1997–2004The Pediatric Infectious Disease Journal, 2006
- Rotavirus and Severe Childhood DiarrheaEmerging Infectious Diseases, 2006
- Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus GastroenteritisNew England Journal of Medicine, 2006
- Rotavirus and Rotavirus VaccinesAdvances in experimental medicine and biology, 2005
- Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccineReviews in Medical Virology, 2004